Cited by 15Pluripotent Stem Cells ResearchCRISPR and Genetic EngineeringTelomeres, Telomerase, and Senescence

Potential Pitfall of Pluripotent Stem Cells

Trounson, Alan·2017·New England Journal of Medicine

Abstract

Stem cells (either embryonic or induced) sometimes develop mutations in tumor-suppressor genes in vitro.

Integrity signals

Registry

Crossref · 10.1056/nejmcibr1706906

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • For pluripotent stem cells (ESCs or iPSCs), there appears to be a selection advantage for mutations of some oncogenes, in particular TP53 and BCOR, which can become fixed in culture.

    “For pluripotent stem cells—embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs)—there appears to be a selection advantage for mutations of some oncogenes, in particular for TP53 and BCOR, which can become fixed in culture74,75.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Trounson, A.
Affiliations
Hudson Institute of Medical Research (AU)
Corresponding author
Trounson, Alan
Venue
New England Journal of Medicine
Published
2017-08-03
Volume
377
Issue
5
Pages
490-491
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2741975582
Cited by
15
References
4
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 5
FWCI
1.01
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
Keywords
pluripotent stem cells, induced pluripotent stem cells, embryonic stem cells, tumor suppressor, somatic mutations, in vitro culture, cancer risk
MeSH terms
Human Embryonic Stem Cells, Cell Differentiation, Humans, Mutation, Proto-Oncogene Proteins, Repressor Proteins, Genes, p53, Tumor Suppressor Protein p53, Pluripotent Stem Cells, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review